Live Breaking News & Updates on Cytosorbent hemodefend

The U.S. Department of Defense Awards CytoSorbents an Approximately $2.0M Contract to Support HemoDefend-BGA™ Development for Life-saving Universal Plasma

PRINCETON, N.J., Sept. 9, 2022 /PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions i.

United-states , Russia , Ukraine , Maryann-gruda , Eric-kim , Amy-vogel , Cytosorbent-hemodefend , Vincent-capponi , Twitter , Department-of-defense , Material-command , Us-department-of-defense-do